In that study, data were analyzed from a total of 100 patients that included only 30 (30%) with CKD stage G1/G2; although FGF23 was significantly correlated with LVMI and low LVEF among the whole study population, the correlations were not statistically significant among patients with no-CKD. The gene discussed is FGF23; the disease is chronic kidney disease.